Article
Synergistic binding of actinomycin D and echinomycin to DNA mismatch sites and their combined anti-tumour effects
15 Mar 2023
Abstract excerpt
Combination cancer chemotherapy is one of the most useful treatment methods to achieve a synergistic effect and reduce the toxicity of dosing with a single drug. Here, we use a combination of two well-established anticancer DNA intercalators, actinomycin D (ActD) and echinomycin (Echi), to screen their binding capabilities with DNA duplexes containing different mismatches embedded within Watson-Crick base-pairs....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
